Table 1.
Animal model | Tissue/sample types | Methods of 4-HNE detection | 4-HNE/4-HNE adduct levels | References |
---|---|---|---|---|
Rats | Blood Plasma | HPLC | 5–75 mmol/l | [61] |
Rats | Feces | 0.10–0.15 μM | [62] | |
CCI4 treated F344 rats | Liver DNA | ~37-fold increase in 4-HNE adducts vs. WT | [63] | |
Obese mice | Epididymal adipose tissue | MS/MS | ~2–3-fold increase in 4-HNE adducts | [64] |
Rat | Plasma | GC-MS | 2.5–250 nmol/L | [65] |
Spontaneously hypertensive rats | Blood/plasma | ~1.8-fold increase in 4-HNE adducts vs. control | [66] | |
CCI4 treated rats | Plasma | ~0.2–183.7 ng/ml | [67] | |
Zucker obese rats | Urines | LC-MS/MS | 0.01–0.075 nM/ml | [68] |
Mice | Liver | 107 ± 7 – 240 ± 8pmol/100mg tissue weight | [69] | |
Obese patients | Blood | Immunodetection (ELISA) | ~1.75-fold increases 4-HNE adducts vs. normal subjects | [70] |
Diabetic mice | Heart | Immunodetection (Western blot) | ~3-fold increase vs. control | [46] |
CCl4: carbon tetrachloride; HPLC: high-performance liquid chromatography; MS: mass spectrometry; GC: gas chromatography; LC: liquid chromatography; and ELISA: enzyme linked immunosorbent assay.